Concepedia

A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer

Kyong Hwa Park, Seoul Lee, Jin‐hong Park, Seok Yun Kang, H. Y. Kim, I. H. Park, Young Hyun Park, Young‐Hyuck Im, H. J. Lee, S. Park,

Supportive Care in Cancer · 2016 · 13 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

Marc L. Citron, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2003 · 1.6K citations

, , +15

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

Nicole M. Kuderer, David C. Dale, Jeffrey Crawford et al. · Cancer · 2006 · 1.2K citations · Full text

, , +6

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

, , +13

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

W. C. Wood, Ronald D. Hart, Anne Moore et al. · New England Journal of Medicine · 1994 · 582 citations · Full text

, , +10

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

Daniel R. Budman, Donald A. Berry, Constance Cirrincione et al. · JNCI Journal of the National Cancer Institute · 1998 · 582 citations

, , +17